• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚乙二醇化对雾化过程中及肺表面活性剂中脂质体稳定性的影响。

Effect of PEGylation on the stability of liposomes during nebulisation and in lung surfactant.

作者信息

Anabousi Samah, Kleemann Elke, Bakowsky Udo, Kissel Thomas, Schmehl Thomas, Gessler Tobias, Seeger Werner, Lehr Claus-Michael, Ehrhardt Carsten

机构信息

Department of Biopharmaceutics and Pharmaceutical Technology, Saarland University, 66123 Saarbrücken, Germany.

出版信息

J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3010-6. doi: 10.1166/jnn.2006.461.

DOI:10.1166/jnn.2006.461
PMID:17048512
Abstract

Oral inhalation of anticancer drugs or drug delivery system is a novel therapeutic approach in the treatment of lung cancer and requires formulations which are sufficiently stabile during nebulisation and subsequent interaction with the surfactant lining of the lungs. In this study, we assessed the stability of plain and PEGylated transferrin-conjugated liposomes after nebulisation using two different nebulisers (i.e., air-jet and ultrasonic type). Furthermore, the integrity of the liposomal membranes was assessed after incubation in commercial lung surfactant solutions (Alveofact). All liposomal formulations showed no significant changes in their size after nebulisation, independent of the type of nebuliser or the liposomal formulation, respectively. However, PEGylation was of advantage when it came to interactions between liposomes and the surfactant lining of the lungs. PEGylated liposomes were significantly more stable and retained > 80% of their drug load over 48 h, which is more than sufficient time for the drug carriers to be taken up by transferrin receptor over-expressing cancer cells in the lung. In conclusion, PEGylated and plain Tf-conjugated liposomes are stable enough to undergo nebulisation in the course of an inhalational therapy, but PEG-stabilisation results in a higher degree of membrane integrity in lung surfactant.

摘要

口服吸入抗癌药物或药物递送系统是治疗肺癌的一种新型治疗方法,需要在雾化过程中以及随后与肺表面活性剂衬里相互作用时足够稳定的制剂。在本研究中,我们使用两种不同的雾化器(即空气喷射式和超声式)评估了雾化后普通和聚乙二醇化转铁蛋白共轭脂质体的稳定性。此外,在商业肺表面活性剂溶液(Alveofact)中孵育后评估脂质体膜的完整性。所有脂质体制剂在雾化后其大小均无显著变化,分别与雾化器类型或脂质体制剂无关。然而,在脂质体与肺表面活性剂衬里的相互作用方面,聚乙二醇化具有优势。聚乙二醇化脂质体明显更稳定,在48小时内保留了超过80%的药物负载量,这对于药物载体被肺中转铁蛋白受体过表达的癌细胞摄取来说时间绰绰有余。总之,聚乙二醇化和普通转铁蛋白共轭脂质体足够稳定,可在吸入治疗过程中进行雾化,但聚乙二醇化稳定作用可使肺表面活性剂中的膜完整性更高。

相似文献

1
Effect of PEGylation on the stability of liposomes during nebulisation and in lung surfactant.聚乙二醇化对雾化过程中及肺表面活性剂中脂质体稳定性的影响。
J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3010-6. doi: 10.1166/jnn.2006.461.
2
Compatibility of PEGylated Polymer Nanoparticles with the Biophysical Function of Lung Surfactant.聚乙二醇化聚合物纳米粒子与肺表面活性剂生物物理功能的相容性。
Langmuir. 2018 Jan 9;34(1):540-545. doi: 10.1021/acs.langmuir.7b03818. Epub 2017 Dec 19.
3
Surfactant nebulisation: safety, efficiency and influence on surface lowering properties and biochemical composition.表面活性剂雾化:安全性、有效性及其对表面降低特性和生化组成的影响。
Intensive Care Med. 1997 Apr;23(4):456-62. doi: 10.1007/s001340050358.
4
Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats.转铁蛋白偶联脂质体靶向递送至裸鼠肺癌原位模型。
J Aerosol Med Pulm Drug Deliv. 2012 Dec;25(6):310-8. doi: 10.1089/jamp.2011.0928. Epub 2012 Aug 2.
5
In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis.体外评价载异烟肼表面活性剂脂质体吸入剂作为肺结核辅助治疗的作用。
J Biomed Mater Res B Appl Biomater. 2010 Jul;94(1):1-10. doi: 10.1002/jbm.b.31608.
6
Nano-liposomal dry powder inhaler of Amiloride Hydrochloride.盐酸阿米洛利纳米脂质体干粉吸入剂
J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3001-9. doi: 10.1166/jnn.2006.405.
7
PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.美洛昔康聚乙二醇化脂质体:基于质量源于设计的优化、体外表征及细胞毒性评价
Pharm Nanotechnol. 2017;5(2):119-137. doi: 10.2174/2211738505666170428152129.
8
Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.包封于 PEG-脂质体中并不会提高肺递送鲑鱼降钙素的生物利用度。
J Aerosol Med Pulm Drug Deliv. 2014 Feb;27(1):1-11. doi: 10.1089/jamp.2013.1049. Epub 2013 Nov 19.
9
An investigation of some of the factors influencing the jet nebulisation of liposomes.影响脂质体喷射雾化的一些因素的研究。
Int J Pharm. 2000 Aug 25;204(1-2):69-79. doi: 10.1016/s0378-5173(00)00477-4.
10
A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.从阳离子聚乙二醇化脂质体阿霉素制剂的药物-基因递送来推导的纳米脂质体药物释放动力学的综合数学模型。
Artif Cells Nanomed Biotechnol. 2018 Feb;46(1):169-177. doi: 10.1080/21691401.2017.1304403. Epub 2017 Apr 4.

引用本文的文献

1
Nebulized Hybrid Nanoarchaeosomes: Anti-Inflammatory Activity, Anti-Microbial Activity and Cytotoxicity on A549 Cells.雾化混合纳米古脂质体:对A549细胞的抗炎活性、抗菌活性及细胞毒性
Int J Mol Sci. 2025 Jan 4;26(1):392. doi: 10.3390/ijms26010392.
2
Dual folate/biotin-decorated liposomes mediated delivery of methylnaphthazarin for anti-cancer activity.双叶酸/生物素修饰的脂质体介导的甲基萘蒽嗪递药用于抗癌活性。
Sci Rep. 2024 Sep 18;14(1):21796. doi: 10.1038/s41598-024-72532-7.
3
Nebulization and Upper Airway Deposition of Liposomal Carrier Systems.
脂质体载体系统的雾化和上呼吸道沉积。
Mol Pharm. 2024 Apr 1;21(4):1848-1860. doi: 10.1021/acs.molpharmaceut.3c01146. Epub 2024 Mar 11.
4
Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases.脂质体改善肺泡疾病吸入药物递送的机制。
Adv Nanobiomed Res. 2023 Mar;3(3):2200106. doi: 10.1002/anbr.202200106. Epub 2023 Jan 27.
5
Nanoparticular and other carriers to deliver lactoferrin for antimicrobial, antibiofilm and bone-regenerating effects: a review.纳米颗粒和其他载体递送乳铁蛋白用于抗菌、抗生物膜和骨再生作用:综述。
Biometals. 2023 Jun;36(3):709-727. doi: 10.1007/s10534-022-00455-9. Epub 2022 Dec 13.
6
Highly Stable Liposomes Based on Tetraether Lipids as a Promising and Versatile Drug Delivery System.基于四醚脂质的高度稳定脂质体作为一种有前景的多功能药物递送系统。
Materials (Basel). 2022 Oct 9;15(19):6995. doi: 10.3390/ma15196995.
7
Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update.基于脂质的纳米载体用于肺癌治疗的抗癌药物肺部递送:最新进展
Pharmaceuticals (Basel). 2021 Jul 27;14(8):725. doi: 10.3390/ph14080725.
8
Oxidation-Triggerable Liposome Incorporating Poly(Hydroxyethyl Acrylate--Allyl methyl sulfide) as an Anticancer Carrier of Doxorubicin.负载聚(丙烯酸羟乙酯-烯丙基甲基硫醚)的氧化触发脂质体作为阿霉素的抗癌载体
Cancers (Basel). 2020 Jan 10;12(1):180. doi: 10.3390/cancers12010180.
9
Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention.肺癌吸入治疗:纳米载体的组成、大小和形状对其肺部蓄积和滞留的影响。
Cancer Biol Med. 2014 Mar;11(1):44-55. doi: 10.7497/j.issn.2095-3941.2014.01.004.
10
Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice.一种仅用于鼻腔暴露的装置的特性与应用,用于向小鼠递送达比药物和核酸的吸入制剂。
J Aerosol Med Pulm Drug Deliv. 2013 Dec;26(6):345-54. doi: 10.1089/jamp.2011-0966. Epub 2013 Mar 26.